Fingolimod effects on the brain are mediated through biochemical modulation of bioenergetics, autophagy, and neuroinflammatory networks-Reference-Cited by-同舟云学术

Fingolimod effects on the brain are mediated through biochemical modulation of bioenergetics, autophagy, and neuroinflammatory networks

Published:2022-08-08 Issue:19-20 Volume:22 Page:2100247
ISSN:1615-9853
Container-title:PROTEOMICS
language:en
Short-container-title:Proteomics

Author:

Mirzaei Mehdi¹^ORCID,Abyadeh Morteza²,Turner Anita J.¹,Wall Roshana Vander¹,Chick Joel M.³,Paulo Joao A.³^ORCID,Gupta Veer K.⁴,Basavarajappa Devaraj¹,Chitranshi Nitin¹,Mirshahvaladi Seyed Shahab Oddin¹,You Yuyi¹,Fitzhenry Matthew J.⁵,Amirkhani Ardeshir⁵,Haynes Paul A.⁶⁷^ORCID,Klistorner Alexander¹,Gupta Vivek¹,Graham Stuart L.¹

Affiliation:

1. Department of Clinical Medicine Faculty of Medicine Health and Human Sciences Macquarie Medical School Macquarie University Macquarie Park, North Ryde Sydney NSW Australia

2. ProGene Technologies Pty Ltd Sydney NSW Australia

3. Department of Cell Biology Harvard Medical School Boston Massachusetts USA

4. School of Medicine Deakin University Geelong VIC Australia

5. Australian Proteome Analysis Facility Macquarie University Sydney NSW Australia

6. School of Natural Sciences Macquarie University Macquarie Park NSW Australia

7. Biomolecular Discovery Research Centre Macquarie University Sydney NSW Australia

Funder

National Health and Medical Research Council

Ophthalmic Research Institute of Australia

Macquarie University

Publisher

Wiley

Subject

Molecular Biology,Biochemistry

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/pmic.202100247

Reference79 articles.

1. Effects of fingolimod treatments on alanine transaminase and aspartate transaminase levels in patients with multiple sclerosis;Joni S. S.;International Journal of Physiology, Pathophysiology and Pharmacology,2020

2. Possible regenerative effects of fingolimod (FTY720) in multiple sclerosis disease: An overview on remyelination process

3. Comparison of first-line and second-line use of fingolimod in relapsing MS: The open-label EARLIMS study

4. The efficacy and safety of fingolimod in patients with relapsing multiple sclerosis: A meta‐analysis

5. Potential neuroprotective effect of Fingolimod in multiple sclerosis and its association with clinical variables

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Apolipoprotein ε in Brain and Retinal Neurodegenerative Diseases;aging and disease;2024

2. Fingolimod exerts neuroprotection by regulating S1PR1 mediated BNIP3-PINK1-Parkin dependent mitophagy in rotenone induced mouse model of Parkinson's disease;Neuroscience Letters;2024-01

3. The role of sphingosine-1-phosphate in the development and progression of Parkinson’s disease;Frontiers in Cellular Neuroscience;2023-12-21

4. Multifunctional Nanoparticles and Nanoclusters as a Theranostics and Symptoms Disappearing Agent for Traumatic Brain Injury;Advanced NanoBiomed Research;2023-11-28

5. Proteome-Wide Profiling Using Sample Multiplexing of a Human Cell Line Treated with Cannabidiol (CBD) and Tetrahydrocannabinol (THC);Proteomes;2023-11-02